(Total Views: 55)
Posted On: 09/30/2025 9:08:08 AM
Post# of 89690
$NRXP NRx Re-Files ANDA for Preservative-Free
IV Ketamine (KETAFREE™); Seeks Market
Entry in Existing Indications
https://ir.nrxpharma.com/static-files/76517eb...f487377cb2
IV Ketamine (KETAFREE™); Seeks Market
Entry in Existing Indications
https://ir.nrxpharma.com/static-files/76517eb...f487377cb2